|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-12-17
|
|
pubmed:abstractText |
Irinotecan is an active drug in colorectal cancer. In patients with liver metastases, hepatic arterial infusion of irinotecan could theoretically result in higher exposure to the drug. In order to determine the efficacy of hepatic arterial irinotecan we conducted a phase II study in pretreated patients with liver metastases of colorectal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
59-63
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:14679121-Adult,
pubmed-meshheading:14679121-Aged,
pubmed-meshheading:14679121-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:14679121-Camptothecin,
pubmed-meshheading:14679121-Colorectal Neoplasms,
pubmed-meshheading:14679121-Drug Administration Schedule,
pubmed-meshheading:14679121-Female,
pubmed-meshheading:14679121-Hepatic Artery,
pubmed-meshheading:14679121-Humans,
pubmed-meshheading:14679121-Infusions, Intra-Arterial,
pubmed-meshheading:14679121-Liver Neoplasms,
pubmed-meshheading:14679121-Male,
pubmed-meshheading:14679121-Middle Aged,
pubmed-meshheading:14679121-Neoplasm Metastasis,
pubmed-meshheading:14679121-Topoisomerase I Inhibitors,
pubmed-meshheading:14679121-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver.
|
|
pubmed:affiliation |
Department of Internal Medicine, St Elisabeth Hospital, Hilvarenbeekseweg 60, 5000 LC Tilburg, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
